Memantine
Back to searchMolecule Structure
Scientific Name
Memantine
Description of the Drug
Memantine is an NMDA receptor antagonist used to treat moderate to severe dementia in Alzheimer’s.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01043
http://www.drugbank.ca/drugs/DB01043
Brand Name(s)
Not Available
Company Owner(s)
Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Anchen Pharmaceuticals Inc, Yichang Humanwell Pharmaceutical Co Ltd, Chartwell Life Molecules Llc, Amneal Pharmaceuticals Of New York Llc, Allergan Sales Llc, Zydus Pharmaceuticals Usa Inc, Torrent Pharmaceuticals Ltd, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Glutamate [NMDA] receptor | PROTEIN COMPLEX GROUP | NEGATIVE ALLOSTERIC MODULATOR | CHEMBL2094124 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2688 | ||
PharmGKB | PA10364 | ||
Human Metabolome Database | HMDB0015177 | ||
DrugBank | DB01043 | ||
PubChem: Thomson Pharma | 15147301 | ||
PubChem | 4054 | ||
Mcule | MCULE-3726352671 | ||
LINCS | LSM-5154 | ||
BindingDB | 50062599 | ||
EPA CompTox Dashboard | DTXSID5045174 | ||
DrugCentral | 1679 | ||
Brenda | 72165 | ||
ChemicalBook | CB7436657 | CB22130921 | |
Guide to Pharmacology | 4253 | ||
rxnorm | MEMANTINE HYDROCHLORIDE | MEMANTINE | NAMENDA |
KEGG Ligand | C13736 | ||
ChEBI | 64312 |